aTyr Pharma (LIFE) News Today → These AI trades triggered this morning (545% return) (From Prosper Trading Academy) (Ad) Free LIFE Stock Alerts $1.60 -0.01 (-0.62%) (As of 04/25/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineaTyr Pharma (NASDAQ:LIFE) Stock Passes Above 200-Day Moving Average of $1.54americanbankingnews.com - April 25 at 3:14 AMaTyr Pharma Insiders Placed Bullish Bets Worth US$514.6kfinance.yahoo.com - April 21 at 3:56 PMAtal Incubation Centre - Centre for Cellular and Molecular Biology signs agreement with Thermo Fisher Scientific to advance innovation in Indiamsn.com - April 17 at 5:09 PMaTyr Pharma (NASDAQ:LIFE) Stock Price Crosses Above 200 Day Moving Average of $1.54americanbankingnews.com - April 17 at 3:00 AMaTyr Pharma, Inc. (NASDAQ:LIFE) Shares Sold by Stonepine Capital Management LLCmarketbeat.com - April 9 at 9:43 PMaTyr Pharma to Participate in April Investor Conferencesfinance.yahoo.com - April 1 at 8:08 AMaTyr Pharma to Participate in April Investor Conferencesglobenewswire.com - April 1 at 8:00 AMShort Interest in aTyr Pharma, Inc. (NASDAQ:LIFE) Rises By 167.4%marketbeat.com - March 28 at 2:55 PM3 Penny Stocks That Could Be Multibaggers in the Making: March Editioninvestorplace.com - March 26 at 2:19 PMaTyr Pharma (NASDAQ:LIFE) Given "Buy" Rating at HC Wainwrightmarketbeat.com - March 18 at 6:43 PMRoyal Bank of Canada Cuts aTyr Pharma (NASDAQ:LIFE) Price Target to $16.00marketbeat.com - March 18 at 5:44 PM3 Best Stocks to Buy Now, 3/18/2024, According to Top Analystsmsn.com - March 18 at 1:04 PMaTyr Pharma, Inc.: aTyr Pharma Announces Fourth Quarter and Full Year 2023 Results and Provides Corporate Updatefinanznachrichten.de - March 17 at 8:32 AMRecap: aTyr Pharma Q4 Earningsbenzinga.com - March 16 at 10:33 AMaTyr Pharma Full Year 2023 Earnings: Revenues Disappointfinance.yahoo.com - March 16 at 10:33 AMBuy Rating Affirmed for aTyr Pharma as Lead Candidate efzofitimod Advances in Clinical Trials with Solid Financial Footingmarkets.businessinsider.com - March 15 at 1:55 PMaTyr Pharma Inc (LIFE) Reports Full Year 2023 Financial Results and Corporate Progressfinance.yahoo.com - March 15 at 1:55 PMQ4 2023 aTyr Pharma Inc Earnings Callfinance.yahoo.com - March 15 at 1:55 PMaTyr Pharma, Inc. (NASDAQ:LIFE) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - March 15 at 1:55 PMLIFE Stock Earnings: aTyr Pharma Misses EPS for Q4 2023investorplace.com - March 14 at 10:04 PMAtyr Pharma: Q4 Earnings Snapshotwashingtonpost.com - March 14 at 6:49 PMaTyr Pharma Announces Fourth Quarter and Full Year 2023 Results and Provides Corporate Updateglobenewswire.com - March 14 at 4:00 PMOptions Volatility and Implied Earnings Moves Today, March 14, 2024msn.com - March 14 at 1:49 PMaTyr Pharma's Earnings Outlookbenzinga.com - March 13 at 7:52 PMaTyr Pharma is about to announce earnings — here's what Wall Street expectsmarkets.businessinsider.com - March 13 at 1:46 PMaTyr Pharma (NASDAQ:LIFE) Stock Crosses Above 200 Day Moving Average of $1.51marketbeat.com - March 5 at 5:47 AMaTyr Pharma to Webcast Conference Call Reporting Fourth Quarter and Full Year End 2023 Financial Resultsglobenewswire.com - February 28 at 8:00 AMWe Think aTyr Pharma (NASDAQ:LIFE) Can Afford To Drive Business Growthfinance.yahoo.com - February 23 at 3:28 PMaTyr Pharma Announces Expanded Access Program (EAP) for EFZO-FIT™ Clinical Trial Participantsfinance.yahoo.com - February 21 at 11:39 AMaTyr Pharma (NASDAQ:LIFE) Rating Reiterated by HC Wainwrightmarketbeat.com - February 21 at 11:19 AMaTyr Pharma Announces Expanded Access Program (EAP) for EFZO-FIT™ Clinical Trial Participantsglobenewswire.com - February 21 at 8:00 AMaTyr Pharma (NASDAQ:LIFE) Shares Pass Above 200 Day Moving Average of $1.51marketbeat.com - February 20 at 3:44 AMaTyr Pharma, Inc. (NASDAQ:LIFE) Given Average Recommendation of "Moderate Buy" by Brokeragesmarketbeat.com - February 20 at 1:36 AMThe 3 Best Penny Stocks to Buy in February 2024investorplace.com - February 15 at 7:49 AMAnalysts Offer Insights on Healthcare Companies: aTyr Pharma (LIFE), CVS Health (CVS) and Science 37 (SNCE)markets.businessinsider.com - February 9 at 12:46 PMaTyr Pharma (NASDAQ:LIFE) Stock Price Crosses Above 200 Day Moving Average of $1.52marketbeat.com - February 7 at 6:51 AMAfter losing 23% in the past year, aTyr Pharma, Inc. (NASDAQ:LIFE) institutional owners must be relieved by the recent gainfinance.yahoo.com - February 3 at 10:38 AMaTyr Pharma, Inc. (NASDAQ:LIFE) Sees Significant Drop in Short Interestmarketbeat.com - January 30 at 2:41 PMaTyr Pharma to Present Posters Highlighting Importance of Neuropilin-2 in Immune Regulation at Keystone Symposia on Myeloid Cell Diversityfinance.yahoo.com - January 29 at 1:01 PMaTyr Pharma Announces Howard University President Emeritus Dr. Wayne A. I. Frederick as Advisorfinance.yahoo.com - January 18 at 8:07 AMPromising Potential of aTyr Pharma’s Efzofitimod in Treating Rheumatoid Arthritis and Associated Lung Disease Underpins Buy Ratingmarkets.businessinsider.com - November 15 at 1:40 AMaTyr Pharma Presents Poster Demonstrating Preclinical Effects of Efzofitimod in Rheumatoid Arthritis and Rheumatoid Arthritis-Associated ILD at the ACR Convergence 2023finance.yahoo.com - November 13 at 1:00 PMaTyr Pharma's Market Cap Drops To US$66m Leaving Insiders With Lossesfinance.yahoo.com - November 13 at 1:00 PMaTyr Pharma files for $300M mixed-shelf offeringmsn.com - November 13 at 7:59 AMRBC Capital Keeps Their Buy Rating on aTyr Pharma (LIFE)markets.businessinsider.com - November 11 at 11:34 PMRobust Financial Health and Promising Clinical Progress Prompt ‘Buy’ Rating for aTyr Pharmamarkets.businessinsider.com - November 10 at 8:27 PMaTyr Pharma GAAP EPS of -$0.20, revenue of $0.3Mmsn.com - November 10 at 3:27 PMPalisade Bio Reports Third Quarter 2023 Financial Results and Provides Business Outlookmarkets.businessinsider.com - November 10 at 10:27 AMaTyr Pharma Announces Third Quarter 2023 Results and Provides Corporate Updatefinance.yahoo.com - November 9 at 6:36 PMaTyr Pharma to Present at November Investor Conferencesfinance.yahoo.com - November 1 at 9:28 AM Get aTyr Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for LIFE and its competitors with MarketBeat's FREE daily newsletter. Email Address These AI trades triggered this morning (545% return) (Ad)If you think a market crash is possible in 2024, I don't know why you're not using this yet. Click Here To Get Your Free Copy LIFE Media Mentions By Week LIFE Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LIFE News Sentiment▼0.800.37▲Average Medical News Sentiment LIFE News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LIFE Articles This Week▼21▲LIFE Articles Average Week Get aTyr Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for LIFE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: bluebird bio News Today Vigil Neuroscience News Today Outlook Therapeutics News Today Cardiol Therapeutics News Today Sangamo Therapeutics News Today BioAtla News Today Curis News Today Precision BioSciences News Today Zura Bio News Today Agenus News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LIFE) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss RatingsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding aTyr Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
